Search Results - "Al Rahbi, F"

Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland by McSorley, L. M., Tharmabala, M., Al Rahbi, F., McSorley, K., Chew, S., Evoy, D., Geraghty, J. G., Prichard, R. S., Rothwell, J., McCartan, D. P., McDermott, E. W., Keane, M., Kennedy, M. J., O’Reilly, S., Millen, S. J., Crown, J. P., Smyth, L. M., Kelly, C. M., Quinn, C. M., Walshe, J. M.

“…Purpose Results from TAILOR-X suggest that up to 70% of hormone receptor-positive (HR+) node-negative (N0) ESBC patients (pts) may avoid chemotherapy (CT) with…”
Get full text

Real-world analysis of clinical and economic impact of 21-gene recurrence score in Ireland by McSorley, L. M, Tharmabala, M, Al Rahbi, F, McSorley, K, Chew, S, Evoy, D, Geraghty, J. G

“…Purpose Results from TAILOR-X suggest that up to 70% of hormone receptor-positive (HR+) node-negative (N0) ESBC patients (pts) may avoid chemotherapy (CT) with…”
Get full text

Real-world analysis of clinical and economic impact of 21-gene recurrence score by Chew, S, Evoy, D, Tharmabala, M, McSorley, L. M, Geraghty, J. G, McSorley, K, Al Rahbi, F

“…Purpose Results from TAILOR-X suggest that up to 70% of hormone receptor-positive (HR+) node-negative (N0) ESBC patients (pts) may avoid chemotherapy (CT) with…”
Get full text

SAT-436 CLINICAL AND GENETIC CHARACTERISTICS OF AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE (ARPKD) PATIENTS FROM OMAN AND PKHD1 FOUNDER MUTATIONS by Al Alawi, I., Al Salmi, I., Al Rahbi, F., Al Mawali, A., Sayer, J.

Get full text

SAT-333 Genetic studies of inherited kidney diseases causing chronic kidney disease by Al Alawi, I., Al Mawali, A., Al Rahbi, F., Sayer, J., Al Sami, I.

Get full text

SAT-297 KIDNEY TRANSPLANTATION RECIPIENTS’ EXPERIENCE IN ORGAN TRAFFICKING by AL RAHBI, F.

Get full text

SAT-483 AWARENESS, KNOWLEDGE AND PERCEPTION OF CHRONIC KIDNEY DISEASE PATIENTS AT RENAL MEDICINE OUTPATIENTS’ CLINIC by AL RAHBI, F., AL RAHBI, F., AlSalmi, I.

Get full text